Premier Biomedical Inc: A Glimpse into the Biotechnology Sector
Premier Biomedical, Inc., a company operating within the health care sector, specifically in the biotechnology industry, has been making strides in the development of medical treatments. The company is listed on the OTC Bulletin Board and trades in USD. As of August 27, 2025, the close price of Premier Biomedical’s stock was recorded at $0.001. Over the past year, the stock has experienced significant volatility, with a 52-week high of $0.0021 on September 9, 2024, and a 52-week low of $0.0003 on May 14, 2025.
The company’s market capitalization stands at $719,330, reflecting its current valuation in the market. Despite its innovative approach to medical treatments, Premier Biomedical’s price-to-earnings ratio is currently at -0.05, indicating that the company is not yet profitable.
Premier Biomedical, Inc. is known for its research-driven approach to discovering and developing medical treatments. The company specializes in pain relief products, including patches impregnated with hemp oil extracts, as well as water-based and oil-based roll-on applicators, and oil-based pump spray applicators. These products are part of the company’s efforts to address diverse health concerns through innovative solutions.
For those interested in learning more about Premier Biomedical’s offerings and research initiatives, further information is available on their website, www.premierbiomedical.com . The site provides insights into the company’s mission, product range, and ongoing projects, accessible through the OTC Bulletin Board.
As Premier Biomedical continues to navigate the biotechnology landscape, its focus remains on leveraging research to develop effective medical treatments, aiming to make a significant impact in the health care sector.